ReviewMicrosystems & nanoengineering2026
Active devices and systems for closed-loop neuromodulation.
Review in Microsystems & nanoengineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Neuromodulation has become a central topic in neuroscience and biomedical engineering, as it provides powerful means to interrogate and regulate neural activity and offers promising therapeutic strategies for a wide range of neurological disorders. Conventional neuromodulation approaches predominantly rely on electrode-based electrical stimulation or remote physical stimuli, including optical, chemical, magnetic, and ultrasound-based methods, to influence neuronal excitability and neural circuit dynamics. Recent advances in neuromodulation involve microsystem engineering, nanotechnology, and genetically enabled techniques such as optogenetics. They have achieved increasingly precise and versatile control over neural systems with high spatial and temporal resolution. Owing to their intrinsic capability for integrated sensing, signal amplification, and adaptive regulation, active devices are particularly well suited for system-level implementations of neuromodulation. This review summarizes recent advances in active devices for neuromodulation, with a particular emphasis on their functional roles in neural regulation. By discussing different material platforms and device architectures, this review further provides insights into the rational design of next-generation neural interface systems.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.